Accessibility Menu
LakeShore Biopharma logo

LakeShore Biopharma

(OTC) LSBCF

Current Price$0.10
Market Cap$2.88M
Since IPO (2021)-100%
5 YearN/A
1 Year-91%
1 Month+257%

LakeShore Biopharma Financials at a Glance

Market Cap

$2.88M

Revenue (TTM)

CN¥577.33M

Net Income (TTM)

-CN¥433.70M

EPS (TTM)

$0.00

P/E Ratio

0.01

Dividend

$0.00

Beta (Volatility)

0.54 (Low)

Price

$0.10

Volume

20,000

Open

$0.10

Previous Close

$0.10

Daily Range

$0.10 - $0.10

52-Week Range

$0.03 - $1.48

LSBCF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About LakeShore Biopharma

Industry

Biotechnology

Employees

573

CEO

Xu Wang

Headquarters

Beijing, 102629, CN

LSBCF Financials

Key Financial Metrics (TTM)

Gross Margin

82%

Operating Margin

-14%

Net Income Margin

-16%

Return on Equity

0%

Return on Capital

-16%

Return on Assets

-7%

Earnings Yield

100.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.88M

Shares Outstanding

41.21M

Volume

20.00K

Avg. Volume

5.36K

Financials (TTM)

Gross Profit

CN¥507.19M

Operating Income

-CN¥86.29M

EBITDA

-CN¥48.54M

Operating Cash Flow

-CN¥120.98M

Capital Expenditure

-CN¥17.86M

Free Cash Flow

-CN¥138.84M

Cash & ST Invst.

CN¥28.08M

Total Debt

CN¥414.40M

LakeShore Biopharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2024YOY CHG

Revenue

CN¥135.53M

+27.7%

Gross Profit

CN¥34.41M

-59.5%

Gross Margin

25.39%

N/A

Market Cap

$2.88M

N/A

Market Cap/Employee

$3.81K

N/A

Employees

758

N/A

Net Income

-CN¥181.41M

-63.3%

EBITDA

-CN¥82.62M

-48.4%

Quarterly Fundamentals

Name
Q4 2024YOY CHG

Net Cash

-CN¥386.32M

-31.3%

Accounts Receivable

CN¥501.79M

+16.9%

Inventory

CN¥227.59M

+6.9%

Long Term Debt

CN¥23.50M

-93.6%

Short Term Debt

CN¥390.90M

+1200.5%

Return on Assets

-7.31%

N/A

Return on Invested Capital

-15.89%

N/A

Free Cash Flow

CN¥0.00

N/A

Operating Cash Flow

CN¥0.00

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
OCELOrganicell Regenerative Medicine, Inc.
$2.74-0.27%
IBXNFIBEX Technologies Inc.
$1.00-6.54%
IGXTIntelGenx Technologies Corp.
$0.17+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
ASTCAstrotech
$13.81+4.59%
NOKNokia
$15.68-0.05%
ONDSOndas
$10.80+0.11%
FFord Motor Company
$15.88+0.04%

Questions About LSBCF

What is the current price of LakeShore Biopharma?

LakeShore Biopharma is trading at $0.10 per share.

What is the 52-week range for LakeShore Biopharma?

Over the past 52 weeks, LakeShore Biopharma has traded between $0.03 and $1.48.

How much debt does LakeShore Biopharma have?

As of the most recent reporting period, LakeShore Biopharma reported total debt of CN¥57.73M.

How much cash does LakeShore Biopharma have on hand?

LakeShore Biopharma reported CN¥14.97M in cash and cash equivalents in its most recent financial results.

What is LakeShore Biopharma’s dividend yield?

LakeShore Biopharma does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.